Starton Therapeutics Announces Initial Key Safety and
Study enrollment is ahead of schedule with half of the patients enrolled and complete enrollment is expected by Q3/24Early data may suggest superiority in...
Source: globenewswire.com
About Starton News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from About Starton. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In About Starton Today - Breaking & Trending Today
Starton Therapeutics Announces the Opening of the First Clinical Site for STAR-LLD Lenalidomide Phas
Gabrail Cancer & Research Center activated and open to screen patients, with Nash Gabrail, MD as lead investigatorSite activation comes several months ahead of schedule, significantly accelerating Starton’s clinical program timelinePARAMUS, N.J.--(BUSINESS WIRE)--Starton Therapeutics Inc. (“Starton” or “the Company”...
Source: pharmiweb.com
Starton Therapeutics Receives Authorization from the FDA to Proceed with STAR-LLD Lenalidomide Phase
FDA agrees to the planned Phase 1b study in second-line transplant-ineligible patients in multiple myelomaTreatment regimen will include Velcade® (bortezomib) and dexamethasone and replace oral Revlimid® with STAR-LLDPARAMUS, N.J.--(BUSINESS WIRE)--Starton Therapeutics Inc. (“Starton” or “the Company”), a clinical s...
Source: pharmiweb.com
Starton Therapeutics Receives Authorization from the FDA to Proceed with STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple Myeloma
FDA agrees to the planned Phase 1b study in second-line transplant-ineligible patients in multiple myeloma Treatment regimen will include Velcade® and dexamethasone and replace oral... | June 12, 2023
Source: marketscreener.com